TITLE

Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment

AUTHOR(S)
Zirakzadeh, Ali; Patel, Robin
PUB. DATE
April 2006
SOURCE
Mayo Clinic Proceedings;Apr2006, Vol. 81 Issue 4, p529
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Vancomycin-resistant enterococci (VRE) are becoming a major concern in medical practice. Their increased prevalence and their ability to transfer vancomycin resistance to other bacteria (including methicillin-resistant Staphylococcus aureus) have made them a subject of close scrutiny and intense investigation. Colonization is usually acquired by susceptible hosts in an environment with a high rate of patient colonization with VRE (eg, Intensive care units, oncology units). Vancomycin-resistant enterococci can survive in the environment for prolonged periods (>1 week), can contaminate almost any surface, and can be passed from one patient to another by health care workers. Whether VRE colonization leads to infection depends on the health status of the patient. Whereas immunocompetent patients colonized with VRE are at low risk for infection, weakened hosts (patients with hematologic disorders, transplant recipients, or severely III patients) have an increased likelihood of developing infection following colonization. Quinupristin-dalfopristin and linezolid are among the anti-Infective agents that have recently become available to treat infection caused by VRE. Other antimicrobials are currently under development. Molecular techniques such as polymerase chain reaction and standard culture studies are being used to detect VRE colonization, infection, and outbreaks.
ACCESSION #
20449856

 

Related Articles

  • Molecular Characterization of Glycopeptide-Resistant Enterococci fromHospitals of the Picardy Region (France). Biendo, M.; Adjidé, C.; Castelain, S.; Belmekki, M.; Rousseau, F.; Slama, M.; Ganry, O.; Schmit, J. L.; Eb, F. // International Journal of Microbiology;2010, p1 

    We studied 138 glycopeptide-resistant enterococci (GRE) strains, consisting of 131 glycopeptide-resistant Enterococcus faecium (GREfm) and 7 glycopeptide-resistant Enterococcus faecalis (GREfs). The GREfm strains were resistant to penicillin, ampicillin, vancomycin, and teicoplanin, while the...

  • Survivability of vancomycin resistant enterococci and fitness cost of vancomycin resistance acquisition. Ramadhan, A. A.; Hegedus, E. // Journal of Clinical Pathology;Jul2005, Vol. 58 Issue 7, p744 

    Aims: To investigate the survivability of vancomycin resistant enterococci (VRE) under dry starvation conditions and the fitness cost of vancomycin resistance. Methods: YRE colonies on cotton swabs were incubated at room temperature in a sterile box and cultured weekly until cultures no longer...

  • Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Salem-Bekhit, M. M.; Moussa, I. M. I.; Muharram, M. M.; Alanazy, F. K.; Hefni, H. M. // Indian Journal of Medical Microbiology;Jan2012, Vol. 30 Issue 1, p44 

    Purpose: Vancomycin-resistant enterococci (VRE) pose an emerging problem in hospitals worldwide. The present study was undertaken to determine the occurrence, species prevalence, antibacterial resistance, and phenotypic and genetic characteristics of VRE isolated in Riyadh hospitals, KSA....

  • ENTEROCOCCAL RESISTANCE -- AN OVERVIEW. Marothi, Y. A.; Agnihotri, H.; Dubey, D. // Indian Journal of Medical Microbiology;Oct2005, Vol. 23 Issue 4, p214 

    Nosocomial acquisition of microorganisms resistant to multiple antibiotics represents a threat to patient safety. Here, we review the antimicrobial resistance in Enterococcus, which makes it important nosocomial pathogen. The emergence of enterococci with acquired resistance to vancomycin has...

  • Impact of Vancomycin Resistance on Mortality among Patients with Neutropenia and Enterococcal Bloodstream Infection. DiazGranados, Carlos A.; Jernigan, John A. // Journal of Infectious Diseases;2/15/2005, Vol. 191 Issue 4, p588 

    We performed a retrospective cohort study to measure the impact of vancomycin resistance on clinical outcome for 83 episodes of enterococcal bloodstream infection (BSI; 22 with vancomycin-resistant enterococci [VRE] and 61 with vancomycin-susceptible enterococci [VSE]) in 77 patients with...

  • Susceptibilidad antimicrobiana y bases genéticas de la resistencia de cepas de Enterococcus causantes de infecciones en Cuba. Quiñones Pérez, Dianelys; Abreu Capote, Miriam; Marrero, Deisy; Alvarez, Ana Bertha; Ortiz, Cecilia; Salomé, Francisco; Llop, Alina; del Campo, Rosa // Revista Panamericana de Salud Publica;Dec2011, Vol. 30 Issue 6, p549 

    Objective. To identify infection-causing Enterococcus species in Cuban hospitals and determine their susceptibility to antimicrobial drugs, as well as their resistance mechanisms. Methods. A total of 687 Enterococcus isolates from 30 Cuban hospitals in nine provinces of the country were studied...

  • First vancomycin-resistant blood isolate of Enterococcus faecium in a children's hospital and molecular analysis of the mechanism of resistance. Altun, Belgin; Cengiz, A. Bülent; Kara, Ateş; Ceyhan, Mehmet; Ünal, Serhat; Seçmeer, Gülten; Gür, Deniz // Turkish Journal of Pediatrics;Nov/Dec2008, Vol. 50 Issue 6, p554 

    The first clinical isolate of vancomycin-resistant Enterococcus spp. in Hacettepe University Children's Hospital was isolated from a blood culture of a patient hospitalized in the intensive care unit. He had been on vancomycin therapy for the last four months for consecutive pneumoniae and...

  • Investigación de las resistencias a antimicrobianos en Enterococcus faecium. Casal, María del Mar; Causse, Manuel; Solís, Francisco; Rodríguez-López, Fernando; Casal, Manuel // Revista Española de Quimioterapia;sep2012, Vol. 25 Issue 3, p180 

    We performed a antibiotic resistance study on Enterococcus faecium isolated from intrahospitalary and extrahospitalary samples between 2004 and 2010. Three different samples were studied; urine, blood and wound swabs, considering a strain per patient. We included in the study a global amount of...

  • Dramatic increase in vancomycin-resistant enterococci in Germany. Gastmeier, Petra; Schröder, Christin; Behnke, Michael; Meyer, Elisabeth; Geffers, Christine // Journal of Antimicrobial Chemotherapy (JAC);Jun2014, Vol. 69 Issue 6, p1660 

    Objectives Among European countries, Germany has one of the highest proportions of vancomycin-resistant Enterococcus faecium bloodstream infections. The aim of this study was to investigate the development of vancomycin-resistant enterococci (VRE) in German hospitals and to consider the regional...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics